Skip to Content

2020 Genesystems Inc - Stock Quote TWTG

Rating as of

Morningstar's 2020 Genesystems Inc Stock Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

2020 Genesystems Inc's Company Profile

Business Description

2020 Genesystems Inc is focused on reducing cancer deaths through the development and use of cancer biomarker test development. It pioneers bio-testing and cancer diagnostic tools that address compelling unmet needs. Its digital diagnostics business develops and commercializes A.I. powered cancer screenings tests deliver better tools to improve early detection of the most common cancers globally.

Contact
9430 Key West Avenue, Suite 100
Rockville, MD
T +1 410 457-3716
Sector Healthcare
Industry Diagnostics & Research
Most Recent Earnings
Fiscal Year End Dec 31, 2021
Stock Type
Employees